Загрузка...
Biomarkers and Surrogate Endpoints: How and When might They Impact Drug Development?
As the pharmaceutical industry starts developing novel molecules developed based on molecular biology principles and a better understanding of the human genome, it becomes increasingly important to develop early indicators of activity and/or toxicity. Biomarkers are measurements based on molecular p...
Сохранить в:
| Главный автор: | |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
IOS Press
2002
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3850863/ https://ncbi.nlm.nih.gov/pubmed/12364814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2002/438745 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|